V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008907 | 280011763 | null | null | Curative (C) | 2017-10-24 | 2017-11-03 | DACTINOMYCIN + CYCLO + VINCRISTINE | Y | N | 280029271 | PEMBROLIZUMAB |
| 280008908 | 280011763 | 1.55 | 67 | Adjuvant (A) | 2013-02-11 | 2013-07-01 | Cetuximab + CISPLATIN + FLUOROURACIL | 2 | N | 280029271 | IPILIMUMAB |
| 280008909 | 280006137 | 1.86 | 69.9 | Adjuvant (A) | 2017-01-04 | 2017-07-16 | Sunitinib | 02 | N | 280029273 | ECARBOX |
| 280008910 | 280009215 | 1.65 | 56.6 | Adjuvant (A) | 2016-04-09 | 2016-04-19 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280029277 | EOX |
| 280008911 | 280006138 | 1.76 | null | Disease modification (D) | null | 2017-05-31 | CARBOPLATIN + VINORELBINE | null | null | 280029282 | EOX |
| 280008912 | 280006140 | 1.64 | null | Curative (C) | 2018-01-12 | 2018-02-20 | CHOP R - 21 days | N | Y | 280029291 | DOCETAXEL |
| 280008913 | 280006141 | 1.7 | 65 | Curative (C) | 2014-10-02 | 2014-11-14 | Rituximab | 02 | N | 280029292 | BENDAMUSTINE + RITUXIMAB |
| 280008914 | 280006141 | 1.62 | 79.8 | Palliative (P) | 2015-10-23 | 2015-11-01 | Carbo F | N | Y | 280029292 | VINCRISTINE |
| 280008915 | 280006142 | 1.74 | 70 | Neo-adjuvant (N) | 2015-05-06 | 2015-05-31 | Cyclophosphamide High Dose | 02 | null | 280029293 | CETUXIMAB + MDG |
| 280008916 | 280006144 | 1.7 | 0 | Curative (C) | null | 2017-05-18 | INTERFERON | 02 | N | 280029306 | KESTREL TRIAL |
| 280008917 | 280006145 | 1.8 | 80.95 | Curative (C) | null | 2018-03-02 | VIDE | N | null | 280029308 | IVADO |
| 280008918 | 280009219 | 1.89 | 71 | Curative (C) | 2013-08-10 | 2013-08-20 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | 2 | null | 280029309 | IVADO |
| 280008919 | 280006148 | 1.67 | 83.95 | Curative (C) | 2014-04-06 | 2014-05-01 | Carboplatin + Liposomal Doxorubicin | 2 | N | 280029311 | BCG |
| 280008920 | 280009221 | 1.75 | 85 | Curative (C) | 2017-12-07 | 2017-12-28 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 280029312 | IVADO |
| 280008921 | 280010698 | 1.64 | null | Curative (C) | 2017-10-31 | 2017-12-12 | Trastuzumab 21 day maintenance | 02 | N | 280029312 | IDELALISIB |
| 280008922 | 280006150 | 1.61 | 95 | null | 2017-12-14 | 2017-12-28 | Cyclophosphamide + Vincristine | 02 | N | 280029318 | DOCETAXEL |
| 280008923 | 280006150 | 1.74 | 93 | Palliative (P) | null | 2014-02-18 | Sunitinib | 02 | N | 280029318 | GEDDIS TRIAL |
| 280008924 | 280006151 | 1.76 | 53 | Disease modification (D) | 2013-09-20 | 2013-10-25 | CAPECITABINE + IRINOTECAN | N | N | 280029323 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280008925 | 280006152 | 1.83 | null | Palliative (P) | 2016-06-04 | 2016-06-25 | Ipilimumab | 02 | N | 280029327 | IVADO |
| 280008926 | 280009224 | 1.64 | 65 | Palliative (P) | 2018-09-19 | 2018-09-29 | ECX | N | N | 280029327 | IVADO |
| 280008927 | 280009224 | 1.83 | 80.8 | Palliative (P) | 2015-07-01 | 2015-07-01 | VINCRISTINE | 02 | N | 280029327 | IVADO |
| 280008928 | 280012080 | 1.76 | 65 | Palliative (P) | 2015-03-13 | 2015-03-13 | Carboplatin + Cetux + FU (>Cycle 2) | 02 | Y | 280029331 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280008929 | 280012127 | 1.58 | 75 | Curative (C) | null | 2017-12-03 | Capecitabine | N | N | 280029336 | CARBO + FLUOROURACIL |
| 280008930 | 280012138 | 1.77 | 96 | Palliative (P) | 2013-10-08 | 2015-08-06 | CAPECITABINE + TEMOZOLOMIDE | 02 | null | 280029339 | VIDE |
| 280008931 | 280006153 | 1.79 | 70 | Adjuvant (A) | 2014-11-02 | 2014-11-02 | Capecitabine + Cisplatin | N | N | 280029340 | VINORELBINE |
| 280008932 | 280006154 | null | null | Palliative (P) | 2018-02-21 | 2018-02-22 | Liposomal Doxorubicin 50mg/m2 | null | Y | 280029342 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280008933 | 280006155 | null | null | Palliative (P) | 2016-04-19 | 2016-04-19 | Cisplatin + Fluorouracil + RT 5day | N | N | 280029346 | METHOTREXATE HIGH DOSE |
| 280008934 | 280006156 | 1.76 | null | Adjuvant (A) | 2016-09-03 | 2016-09-03 | IPM | 02 | N | 280029347 | DACTINOMYCIN + VINCRISTINE |
| 280008935 | 280009226 | 1.73 | 18.18 | Adjuvant (A) | 2014-09-05 | 2014-09-05 | MELPHALAN | N | N | 280029352 | VINCRISTINE |
| 280008936 | 280010701 | 1.75 | 69 | Palliative (P) | 2016-02-16 | 2016-05-20 | NIVOLUMAB | 02 | null | 280029356 | IVADO |
| 280008937 | 280006157 | 1.66 | 58.2 | Palliative (P) | 2017-09-04 | 2017-10-07 | FEC | 02 | N | 280029362 | CAPECITABINE + STREPTOZOCIN |
| 280008938 | 280006159 | 1.58 | 54.8 | Curative (C) | 2016-03-29 | 2016-03-29 | OCTREOTIDE | 2 | N | 280029366 | DACARBAZINE |
| 280008939 | 280006159 | null | null | Palliative (P) | 2016-06-15 | 2016-06-22 | EOX | 2 | N | 280029366 | LIPOSOMAL DOXORUBICIN |
| 280008940 | 280011940 | 1.85 | 102 | Curative (C) | 2017-12-14 | 2017-12-19 | UKALL 14 TRIAL | 2 | Y | 280029377 | CAPECITABINE |
| 280008941 | 280006160 | null | 92.7 | null | 2015-02-26 | 2015-03-25 | Carbo F | N | N | 280029380 | CARBO + FLUOROURACIL |
| 280008942 | 280009230 | 1.71 | 83.7 | Palliative (P) | null | 2017-04-16 | CARBOPLATIN + GEMCITABINE | N | N | 280029383 | IVADO |
| 280008943 | 280006163 | 1.8 | 56.6 | Palliative (P) | 2016-05-30 | 2016-05-30 | Bevacizumab + Oxaliplatin +MdG | N | N | 280029388 | VIDE |
| 280008944 | 280006165 | null | 85.3 | Curative (C) | 2017-05-13 | 2017-05-27 | Pazopanib | N | N | 280029388 | DACARBAZINE |
| 280008945 | 280006168 | 1.61 | 61 | null | 2015-04-02 | 2015-05-18 | IVADo | 02 | null | 280029390 | VINORELBINE |
| 280008946 | 280006169 | null | 11.1 | Palliative (P) | 2016-04-05 | 2018-06-02 | Hydroxycarbamide | 02 | N | 280029399 | MELPHALAN |
| 280008947 | 280009233 | 1.71 | 74.4 | Curative (C) | 2014-10-04 | 2014-10-04 | VIA (Ifos 1.5g/m2) | null | Y | 280029418 | GEFITINIB |
| 280008948 | 280009234 | 1.5 | 78.7 | Neo-adjuvant (N) | 2017-08-11 | 2017-08-28 | Capecitabine | N | N | 280029421 | VINCRISTINE |
| 280008949 | 280006175 | 1.87 | 61.3 | Curative (C) | 2013-12-23 | 2014-01-01 | NIVOLUMAB | 02 | N | 280029421 | IFOSFAMIDE + VINCRISTINE |
| 280008950 | 280006176 | 1.79 | 68 | Curative (C) | 2018-03-17 | 2018-03-18 | BCG Intravesical | null | null | 280029424 | CISPLATIN + FLUOROURACIL + RT |
| 280008951 | 280006176 | 1.6 | 90 | Palliative (P) | 2016-03-03 | 2016-03-07 | BLEOMYCIN + CISPLATIN + VINCRISTINE | null | null | 280029424 | DOCETAXEL |
| 280008952 | 280006178 | 1.62 | 61 | Palliative (P) | 2018-04-02 | 2018-05-09 | CHOP R - 21 days | 02 | null | 280029432 | VINCRISTINE |
| 280008953 | 280006178 | 1.62 | null | Neo-adjuvant (N) | 2014-03-18 | 2014-03-18 | VIDE | 02 | N | 280029432 | CISPLATIN + FLUOROURACIL + RT |
| 280008954 | 280006180 | 1.76 | 73.3 | Not known (9) | 2016-11-30 | 2016-12-12 | Sorafenib | N | N | 280029438 | CAPECITABINE |
| 280008955 | 280006182 | 1.61 | 72.5 | Palliative (P) | 2017-02-28 | 2017-04-15 | Bevacizumab 7.5mg/kg | 02 | N | 280029438 | DOXORUBICIN + GEMCITABINE |
| 280008956 | 280006183 | 1.74 | 67 | Curative (C) | 2015-02-04 | 2016-08-01 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280029446 | DACARBAZINE |